Berntsen David A, Mutti Donald O, Zadnik Karla
College of Optometry, The Ohio State University, Columbus, Ohio, USA.
Optom Vis Sci. 2010 Nov;87(11):823-32. doi: 10.1097/OPX.0b013e3181f6f776.
The Study of Theories about Myopia Progression (STAMP) is a 2-year, double-masked, randomized clinical trial of myopic children 6 to 11 years of age. STAMP will evaluate the 1-year effect of progressive addition lenses (PALs) compared with single vision lenses (SVLs) on central refraction, peripheral refraction in four quadrants, and accommodative response and convergence. STAMP will also evaluate any changes 1 year after discontinuing PALs. Baseline characteristics of enrolled children are reported.
Eligible children had a high accommodative lag and either low myopia (less myopic than -2.25 diopter (D) spherical equivalent) or high myopia (more myopic than -2.25 D spherical equivalent) and esophoria at near. Children were randomly assigned to wear either PALs or SVLs for 1 year to determine the difference in myopia progression in the PAL group relative to the SVL group. All children will then wear SVLs for the 2nd year to evaluate the permanence of any treatment effect. Complete ocular biometric data are collected at 6-month intervals.
Over 17 months, 192 children were screened, and 85 (44%) were eligible and enrolled. Of these 85 children, 44 (52%) were girls, and 54 (64%) were esophoric at near. The mean age (± SD) was 9.8 ± 1.3 years. The right eye mean cycloplegic spherical equivalent refractive error was -1.95 ± 0.78 D. Horizontal relative peripheral hyperopia (30° nasal retina + 0.56 ± 0.59 D; 30° temporal retina + 0.61 ± 0.77 D) and vertical relative peripheral myopia (30° superior retina -0.36 ± 0.92 D; 20° inferior retina -0.48 ± 0.83 D) were found.
The baseline data for STAMP are reported. Asymmetry between vertical and horizontal meridian relative peripheral refraction was found. STAMP will use the ocular biometric changes associated with the PAL treatment effect to attempt to elucidate the mechanism responsible for the treatment effect.
近视进展理论研究(STAMP)是一项针对6至11岁近视儿童的为期2年的双盲随机临床试验。STAMP将评估渐进多焦点镜片(PALs)与单焦点镜片(SVLs)相比,对中央屈光、四个象限的周边屈光、调节反应和集合的1年效果。STAMP还将评估停用PALs 1年后的任何变化。报告了入组儿童的基线特征。
符合条件的儿童有较高的调节滞后,且为低度近视(等效球镜度数低于-2.25屈光度(D))或高度近视(等效球镜度数高于-2.25 D),并且近距离内隐斜。儿童被随机分配佩戴PALs或SVLs 1年,以确定PAL组相对于SVL组在近视进展方面的差异。所有儿童在第2年将佩戴SVLs,以评估任何治疗效果的持久性。每隔6个月收集完整的眼部生物测量数据。
在17个月的时间里,筛查了192名儿童,其中85名(44%)符合条件并被纳入研究。在这85名儿童中,44名(52%)为女孩,54名(64%)近距离内隐斜。平均年龄(±标准差)为9.8±1.3岁。右眼平均睫状肌麻痹等效球镜屈光不正为-1.95±0.78 D。发现水平相对周边远视(30°鼻侧视网膜+0.56±0.59 D;30°颞侧视网膜+0.61±0.77 D)和垂直相对周边近视(30°上方视网膜-0.36±0.92 D;20°下方视网膜-0.48±0.83 D)。
报告了STAMP的基线数据。发现垂直和水平子午线相对周边屈光之间存在不对称。STAMP将利用与PAL治疗效果相关的眼部生物测量变化,试图阐明造成治疗效果的机制。